Compass Therapeutics (CMPX) Cash from Investing Activities Growth (1y) (2020 - 2026)
Compass Therapeutics (CMPX) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Compass Therapeutics |
379.32 Mn |
184.64 Mn |
- |
231.63% |
| Date | Value |
|---|
| Mar 31, 2026 |
231.63% |
| Dec 31, 2025 |
-121.98% |
| Sep 30, 2025 |
-427.92% |
| Jun 30, 2025 |
-198.10% |
| Mar 31, 2025 |
382.70% |
| Dec 31, 2024 |
143.43% |
| Sep 30, 2024 |
70.20% |
| Jun 30, 2024 |
1,071.96% |
| Mar 31, 2024 |
-196.02% |
| Dec 31, 2023 |
113.54% |
| Sep 30, 2023 |
1,344.83% |
| Jun 30, 2023 |
99.37% |
| Mar 31, 2023 |
2,311.92% |
| Dec 31, 2022 |
-5,911.08% |
| Sep 30, 2022 |
421.53% |
| Jun 30, 2022 |
-17,089.09% |
| Mar 31, 2022 |
-1,384.62% |
| Sep 30, 2021 |
-1,246.88% |
| Jun 20, 2021 |
-1,674.36% |
| Mar 31, 2021 |
-8.33% |
